Avenue Therapeutics, Inc. (Avenue), a specialty pharmaceutical company, has filed a Form S-3 with the Securities and Exchange Commission (SEC) on May 3, 2024. The filing pertains to the registration of 1,420,741 shares of common stock underlying certain common warrants and placement agent warrants. These warrants were issued in connection with a private placement transaction that closed on May 1, 2024. The Series C and Series D Warrants, exercisable at $6.20 per share, and the Placement Agent Warrants, exercisable at $7.75 per share, are part of the registration. The Series C and Placement Agent Warrants are exercisable immediately and for a period of five years from the date of issuance, while the Series D Warrants are exercisable for eighteen months from issuance. The Selling Stockholders may sell...Show More

Avenue Therapeutics, Inc. (Avenue), a specialty pharmaceutical company, has filed a Form S-3 with the Securities and Exchange Commission (SEC) on May 3, 2024. The filing pertains to the registration of 1,420,741 shares of common stock underlying certain common warrants and placement agent warrants. These warrants were issued in connection with a private placement transaction that closed on May 1, 2024. The Series C and Series D Warrants, exercisable at $6.20 per share, and the Placement Agent Warrants, exercisable at $7.75 per share, are part of the registration. The Series C and Placement Agent Warrants are exercisable immediately and for a period of five years from the date of issuance, while the Series D Warrants are exercisable for eighteen months from issuance. The Selling Stockholders may sell the shares at any time after the effective date of the Registration Statement, through various methods including but not limited to brokerage transactions, block trades, and private sales. Avenue will not receive any proceeds from the sale of the shares by the Selling Stockholders but will receive proceeds from any cash exercise of the warrants. The common stock is listed on The Nasdaq Capital Market under the symbol 'ATXI'.